Aclarion, Inc. (ACON) Financial Statements
Industry: Medical Laboratories (Services)
In fiscal 2025, Aclarion reported revenue of $75,730, up 65.6% from $45,724 the year before. Net income was -$7.2M (a -9551.9% net margin), or -$13.61 per diluted share. Gross margin was 9.0% and operating margin was -9312.5%. Operating activities generated -$7.2M of cash, leaving -$7.2M of free cash flow. At fiscal year end, Aclarion held $13.7M in total assets against $837,287 in total liabilities, including $12.0M of cash and equivalents.
Open the full interactive Aclarion financials → Quarterly statements, key ratios, valuation history and price charts.
Aclarion Key Stats
| Share Price | $2.14 |
|---|---|
| Market Cap | $5.3M |
| Revenue YoY Growth | +65.6% |
| 52-Week Range | $2.02 – $9.69 |
| Shares Outstanding | 2.5 million (basic, 2026 Q2) |
Aclarion Income Statement
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Revenue | $60,444 | $75,404 | $45,724 | $75,730 |
| Gross Profit | -$4,854 | -$324 | -$38,934 | $6,828 |
| Operating Income | -$6.1M | -$4.9M | -$5.5M | -$7.1M |
| Pre-Tax Income | -$7.6M | -$4.9M | -$7.0M | -$7.2M |
| Income Tax | $0 | $0 | $0 | $0 |
| Net Income | -$7.6M | -$4.9M | -$7.0M | -$7.2M |
| Diluted EPS | -$189583.20 | -$79776.90 | -$7.48 | -$13.61 |
Aclarion Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $18,942 | $18,478 | $21,140 | $25,208 |
| Net Income | -$1.7M | -$1.9M | -$2.9M | -$2.7M |
| Diluted EPS | -$2.93 | -$3.55 | -$1.34 | -$1.12 |
Aclarion Balance Sheet
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Cash & Equivalents | $1.5M | $1.0M | $453,661 | $12.0M |
| Current Assets | $2.0M | $1.3M | $824,279 | $12.4M |
| Total Assets | $3.2M | $2.5M | $2.1M | $13.7M |
| Current Liabilities | $1.4M | $3.2M | $1.2M | $837,287 |
| Total Long-Term Debt | — | $2.6M | — | — |
| Total Liabilities | $1.4M | $3.2M | $1.2M | $837,287 |
| Shareholders' Equity | $1.8M | -$727,995 | $970,057 | $12.8M |
Aclarion Cash Flow Statement
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Cash From Operations | -$5.3M | -$3.6M | -$5.3M | -$7.2M |
| Cash From Investing | -$207,870 | -$119,522 | -$321,937 | -$203,902 |
| Cash From Financing | $6.6M | $3.3M | $5.0M | $18.9M |
| Free Cash Flow | — | — | -$5.3M | -$7.2M |
Figures from Aclarion's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Aclarion financials page for every line item.
Aclarion Company Profile
| Ticker | ACON |
|---|---|
| Exchange | Nasdaq |
| Industry | Medical Laboratories (Services) |
| Headquarters | Broomfield, Colorado |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company, emerging growth company |
| SEC CIK | 0001635077 |
Frequently Asked Questions
What was Aclarion's revenue in fiscal 2025?
Aclarion (ACON) reported revenue of $75,730 for fiscal 2025.
What is Aclarion's annual revenue history?
Aclarion's annual revenue by fiscal year: 2022: $60,444; 2023: $75,404; 2024: $45,724; 2025: $75,730.
What was Aclarion's net income in fiscal 2025?
Aclarion reported net income of -$7.2M for fiscal 2025.
What was Aclarion's earnings per share (EPS) in fiscal 2025?
Aclarion's diluted EPS was -$13.61 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Aclarion generate in fiscal 2025?
Aclarion generated -$7.2M of free cash flow in fiscal 2025.
What was Aclarion's revenue last quarter?
In its most recent reported quarter (2026 Q2), Aclarion reported revenue of $25,208.
How many shares of Aclarion are outstanding?
Aclarion reported a weighted average of 2.5 million basic shares outstanding in 2026 Q2.
What is Aclarion's market cap?
Based on its latest closing price, Aclarion (ACON) has a market capitalization of about $5.3M.
When does Aclarion's fiscal year end?
Aclarion's fiscal year end, as registered with the SEC, is December 31.
Where is Aclarion headquartered?
Aclarion lists its business address in Broomfield, Colorado in its SEC filings.